Gilead Sciences
GILD
1,526 hedge funds and large institutions have $66.4B invested in Gilead Sciences in 2017 Q1 according to their latest regulatory filings, with 133 funds opening new positions, 600 increasing their positions, 703 reducing their positions, and 157 closing their positions.
0.61% less ownership
Funds ownership: 75.4% → 74.79% (-0.61%)
3% less funds holding
Funds holding: 1,574 → 1,526 (-48)
4% less funds holding in top 10
Funds holding in top 10: 92 → 88 (-4)
7% less capital invested
Capital invested by funds: $71.2B → $66.4B (-$4.77B)
15% less repeat investments, than reductions
Existing positions increased: 600 | Existing positions reduced: 703
15% less first-time investments, than exits
New positions opened: 133 | Existing positions closed: 157
36% less call options, than puts
Call options by funds: $1.47B | Put options by funds: $2.28B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.99B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$436M |
| 3 |
Parnassus Investments
San Francisco,
California
|
+$320M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$215M |
| 5 |
Bank of New York Mellon
New York
|
+$192M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.15B |
| 2 |
JP Morgan Chase
New York
|
-$608M |
| 3 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$379M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$334M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$232M |
GILD Hedge Fund Activity: Q1 2017 in Review
1,526 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q1 2017, worth a combined $66.4B — down 6.7% from $71.2B a quarter earlier.
Sellers outnumbered buyers: 157 funds closed out of GILD and 133 opened new positions — a net loss of 24 holders — while 703 trimmed existing stakes and 600 added.
The largest buyer was BlackRock, adding an estimated $6.99B. The largest seller was Fidelity Investments, cutting an estimated $1.15B.
- 1,526 institutional investors held Gilead Sciences (GILD) as of Q1 2017, down from 1,574 in Q4 2016.
- Funds reported $66.4B of Gilead Sciences stock for Q1 2017, down 6.7% quarter-over-quarter.
- 133 funds opened new Gilead Sciences positions in Q1 2017 and 157 closed out, a net change of -24 holders.
- The largest Gilead Sciences buyer in Q1 2017 was BlackRock, an estimated $6.99B added.
- The largest Gilead Sciences seller in Q1 2017 was Fidelity Investments, an estimated $1.15B sold.
Based on aggregated 13F filings for Q1 2017.